IL188937A0 - Hybrid polypeptides with selectable properties - Google Patents

Hybrid polypeptides with selectable properties

Info

Publication number
IL188937A0
IL188937A0 IL188937A IL18893708A IL188937A0 IL 188937 A0 IL188937 A0 IL 188937A0 IL 188937 A IL188937 A IL 188937A IL 18893708 A IL18893708 A IL 18893708A IL 188937 A0 IL188937 A0 IL 188937A0
Authority
IL
Israel
Prior art keywords
hybrid polypeptides
selectable properties
selectable
properties
polypeptides
Prior art date
Application number
IL188937A
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/206,903 external-priority patent/US8076288B2/en
Priority claimed from US11/301,744 external-priority patent/US7723471B2/en
Priority claimed from PCT/US2006/031724 external-priority patent/WO2007022123A2/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of IL188937A0 publication Critical patent/IL188937A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL188937A 2005-08-11 2008-01-22 Hybrid polypeptides with selectable properties IL188937A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20166405A 2005-08-11 2005-08-11
US11/206,903 US8076288B2 (en) 2004-02-11 2005-08-17 Hybrid polypeptides having glucose lowering activity
US11/301,744 US7723471B2 (en) 2004-02-11 2005-12-12 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
PCT/US2006/031724 WO2007022123A2 (en) 2005-08-11 2006-08-11 Hybrid polypeptides with selectable properties

Publications (1)

Publication Number Publication Date
IL188937A0 true IL188937A0 (en) 2008-04-13

Family

ID=39662713

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188937A IL188937A0 (en) 2005-08-11 2008-01-22 Hybrid polypeptides with selectable properties

Country Status (7)

Country Link
JP (1) JP2009504681A (en)
KR (1) KR101399178B1 (en)
CN (1) CN101296942A (en)
EA (1) EA014647B1 (en)
IL (1) IL188937A0 (en)
MX (1) MX2008002028A (en)
ZA (1) ZA200801138B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2416797A4 (en) * 2009-04-10 2013-04-24 Amylin Pharmaceuticals Llc Amylin agonist compounds for estrogen-deficient mammals
RU2012126101A (en) * 2009-11-23 2013-12-27 АМИЛИН ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи,США POLYEPEPTIDE CONJUGATE
GB201001333D0 (en) * 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
SG184988A1 (en) * 2010-04-27 2012-11-29 Zealand Pharma As Peptide conjugates of glp-1 receptor agonists and gastrin and their use
RU2552221C2 (en) * 2010-07-15 2015-06-10 Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" Method of treating obesity and accompanying metabolic disorders and medication for treating obesity and accompanying metabolic disorders
EP2714069A4 (en) * 2011-05-25 2015-06-24 Amylin Pharmaceuticals Llc Long duration dual hormone conjugates
TWI674270B (en) * 2012-12-11 2019-10-11 英商梅迪繆思有限公司 Glucagon and glp-1 co-agonists for the treatment of obesity
CN106794225A (en) * 2014-08-11 2017-05-31 奥尔巴尼医学院 Leptin related peptide of myristoylation and application thereof
KR101689803B1 (en) * 2015-11-17 2016-12-27 고려대학교 산학협력단 Composition for preventing or treating of diabetes or obesity containing Apelin-16
CN116063580A (en) * 2016-01-04 2023-05-05 艾得佩索拉公司 Peptide analogues
JP6889432B2 (en) * 2016-04-28 2021-06-18 学校法人甲南学園 Resin-fixed peptide
WO2018045155A1 (en) * 2016-09-02 2018-03-08 The Board Of Trustees Of The University Of Illinois Kif13b-derived peptide and method of inhibiting angiogenesis
JP7202011B2 (en) * 2017-09-13 2023-01-11 キッズウェル・バイオ株式会社 Anti-RAMP2 antibody
TWI847981B (en) * 2018-04-25 2024-07-11 比利時商健生藥品公司 Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
US10875902B2 (en) 2018-04-25 2020-12-29 Janssen Pharmaceutica Nv Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
KR102116944B1 (en) * 2019-09-23 2020-05-29 주식회사 차메디텍 Novel peptide derivatives having melanin production inhibitory activity, pharmaceutically acceptable salts thereof, and composition for inhibiting melanin production comprising the same
CN117603364A (en) * 2022-09-30 2024-02-27 广西医科大学附属肿瘤医院 GLP-1/glucon/Y 2 Receptor triple agonists and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
CA2246431A1 (en) * 1996-01-19 1997-07-24 Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
AU1159897A (en) 1996-11-13 1998-06-03 University Of Cincinnati, The Analogs of peptide yy and uses thereof
IL130396A (en) * 1996-12-20 2011-09-27 Amgen Inc Ob fusion protein, nucleic acid sequence, vector, cell, process for producing said protein and pharmaceutical composition
US6506724B1 (en) * 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
US6528486B1 (en) * 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
DE60105547T3 (en) * 2000-01-10 2014-12-31 Amylin Pharmaceuticals, Llc USE OF EXENDINES AND THEIR AGONISTS FOR THE TREATMENT OF HYPERTRIGLIC CERIDEMIA
KR20080085082A (en) * 2000-12-07 2008-09-22 일라이 릴리 앤드 캄파니 Glp-1 fusion proteins
US7576050B2 (en) * 2001-07-31 2009-08-18 The United States Of America As Represented By The Department Of Health And Human Services GLP-1 exendin-4 peptide analogs and uses thereof
US7192922B2 (en) * 2002-11-19 2007-03-20 Allegheny-Singer Research Institute Method of treating left ventricular dysfunction
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
AU2003297356A1 (en) * 2002-12-17 2004-07-14 Amylin Pharmaceuticals, Inc. Prevention and treatment of cardiac arrhythmias
WO2004089279A2 (en) * 2003-04-08 2004-10-21 Yeda Research And Development Co. Ltd. Long-acting derivatives of pyy agonists
BRPI0507594A (en) * 2004-02-11 2007-07-03 Amylin Pharmaceuticals Inc hybrid polypeptides with selectable properties

Also Published As

Publication number Publication date
KR20080045185A (en) 2008-05-22
EA014647B1 (en) 2010-12-30
CN101296942A (en) 2008-10-29
EA200800548A1 (en) 2008-08-29
MX2008002028A (en) 2008-03-27
JP2009504681A (en) 2009-02-05
ZA200801138B (en) 2008-12-31
KR101399178B1 (en) 2014-06-18

Similar Documents

Publication Publication Date Title
IL177229A0 (en) Hybrid polypeptides with selectable properties
IL188937A0 (en) Hybrid polypeptides with selectable properties
IL184428A0 (en) Peptides with neuropeptide-2-receptor
IL185563A0 (en) Gip analog and hybrid polypeptides with selectable properties
GB0524788D0 (en) Polypeptides
EP1928237A4 (en) Novel imidazo based heterocycles
EP2209394A4 (en) The armpocket
ZA200810738B (en) Polypeptide
EP1948985A4 (en) Improved fitting with complementary fitting materials
GB0721686D0 (en) Polypeptides
EP1868428A4 (en) Rubber-fiber hybrid
EP1882128A4 (en) Electric range
GB2443971B (en) Mechanical override
ZA200806320B (en) Diazepinones
GB0601471D0 (en) The cardioprotector
GB0505949D0 (en) Polypeptides
GB0623539D0 (en) Polypeptides
GB0712302D0 (en) Chrondroitinase polypeptides
IL231953A0 (en) Hybrid polypeptides with selectable properties
GB0521784D0 (en) Fuel system - 8
GB0602141D0 (en) The turboramjet
GB0504769D0 (en) Polypeptides
AU3316P (en) Zanlortrofeo Lilium hybrid
AU3314P (en) Zanlorvenna Lilium hybrid
AU3315P (en) Zanlotriumph Lilium hybrid